{
  "doc_id": "SLC13A5-Epileptic-Encephalopathy",
  "doc_filename": "SLC13A5-Epileptic-Encephalopathy.pdf",
  "trial_ids": [],
  "study_design": null,
  "eligibility_inclusion": [],
  "eligibility_exclusion": [],
  "epidemiology": [],
  "patient_journey": [],
  "endpoints": [],
  "sites": [
    {
      "field_type": "STUDY_SITE",
      "text": "United States",
      "section": "sites",
      "page": null,
      "structured_data": {
        "country": "United States",
        "site_count": null
      },
      "confidence": 0.85,
      "evidence": []
    },
    {
      "field_type": "STUDY_SITE",
      "text": "European countries",
      "section": "sites",
      "page": null,
      "structured_data": {
        "country": "European countries",
        "site_count": null
      },
      "confidence": 0.85,
      "evidence": []
    },
    {
      "field_type": "STUDY_SITE",
      "text": "South American countries",
      "section": "sites",
      "page": null,
      "structured_data": {
        "country": "South American countries",
        "site_count": null
      },
      "confidence": 0.85,
      "evidence": []
    }
  ],
  "operational_burden": {
    "invasive_procedures": [],
    "visit_schedule": {
      "total_visits": null,
      "visit_days": [],
      "frequency": null,
      "duration_weeks": null,
      "scheduled_visits": [],
      "pre_randomization_days": [],
      "on_treatment_days": [],
      "follow_up_days": [],
      "evidence": []
    },
    "central_lab_required": false,
    "central_lab": null,
    "special_sample_handling": [],
    "vaccination_requirements": [],
    "background_therapy": [],
    "concomitant_meds_allowed": [],
    "run_in_duration_days": null,
    "run_in_requirements": [],
    "burden_score": null,
    "site_complexity_score": null,
    "hard_gates": []
  },
  "screening_flow": null,
  "extraction_timestamp": "2026-02-04T23:42:21.738946"
}